Cite
MLA Citation
Jianxing He et al.. “Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.” Lancet, vol. 9, no. 9, 2021, pp. 1021–1029. http://access.bl.uk/ark:/81055/vdc_100144251782.0x000013